Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Eligibility Matched Benchmarking of Second-Line Anti-CD19 CAR-T and Glofit-GemOx (STARGLO) Outcomes in Large B-Cell Lymphoma.

Created on 26 Jul 2026

Authors

Gil Fridberg, Odelia Amit, Muhammad Ganayem, Chava Perry, Yair Herishanu, Erel Joffe, Tamir Shragai, Roy Vitkon, Nili Eilati, Ronit Gold, Orit Sofer, Nadav Sarid, Shoshan Perk, Katrin Herzog Tzarfati, Sharon Ben Barouch, Irit Avivi, Ron Ram

Published in

Transplantation and cellular therapy. Jul 25, 2026. Epub Jul 25, 2026.

PMID:
42501867
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement